RHINOCORT

This brand name is authorized in Canada, Estonia, France, Germany, Hong Kong SAR China, Lithuania, Mexico, Netherlands, Singapore, South Africa, Spain.

Active ingredients

The drug RHINOCORT contains one active pharmaceutical ingredient (API):

1	Budesonide UNII Q3OKS62Q6X - BUDESONIDE
	Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.
	Read more about Budesonide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R01AD05	Budesonide	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids
Discover more medicines within R01AD05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02231923
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01888602
EE	Ravimiamet	1043389
ES	Centro de información online de medicamentos de la AEMPS	64730
FR	Base de données publique des médicaments	61741918
HK	Department of Health Drug Office	46604, 46605
LT	Valstybinė vaistų kontrolės tarnyba	1003824, 1009787, 1067929, 1071735
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	270M98
NL	Z-Index G-Standaard	13603299, 13754580
NL	Z-Index G-Standaard, PRK	37397, 63711
SG	Health Sciences Authority	07588P, 10374P
ZA	Health Products Regulatory Authority	32/21.5.1/0608, 32/21.5.1/0609